Biotech

All Articles

Lykos 'regrets' certainly not revealing research transgressions with author

.Psychopharmacology has drawn 3 posts concerning midstage clinical test information examining Lykos ...

Analysts dig into Avidity's DMD win, exposing nuances in records

.Avidity Biosciences amazed real estate investors along with stage 1/2 information in Duchenne muscu...

Actinogen's cortisol blocker neglects phase 2 clinical depression research study

.Actinogen Medical's cortisol blocker has actually skipped the primary endpoint of a period 2 resear...

Bivictrix determines going private only means to take ADC right into clinic

.Antibody-drug conjugates (ADCs) have actually gone to the facility of many a billion-dollar biobuck...

TPG leadings up funds to $580M for financial investments throughout life scientific researches

.Resource manager TPG, which has supported biotechs including Sionna Rehabs and also Santa Clam Ana ...

Merck quits phase 3 TIGIT test in bronchi cancer cells for futility

.Merck &amp Co.'s TIGIT plan has experienced another setback. Months after shuttering a stage 3 canc...

After a challenging year, Exscientia folds up right into Recursion

.After a year defined through pipeline hairstyles, the variation of its chief executive officer and ...

Cullinan, after $25M deal, hands back bispecific to Port

.Cullinan Therapy was actually made an impression on sufficient along with Port BioMed's bispecific ...

A closer take a look at Intense Biotech's Tough 15

.In this week's incident of "The Leading Pipe," our team're diving in to Intense Biotech's yearly Fe...

Lilly deals with period 2 breakdown of tau-targeting med

.The confetti is still soaring from Eli Lilly's event commemorating the approval of Alzheimer's dise...